Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)

Aim of investigation. To compare results of radical surgery in IBD-associated colorectal cancer (IBD-CRC) and sporadic colorectal cancer (spCRC) patients. Material and methods. The main group included retrospective cases of IBD-CRC with total colectomy and D3 lymph node (LN) dissection. The control...

Full description

Bibliographic Details
Main Authors: P. V. Tsarkov, I. A. Tulina, S. K. Efetov, Yu. E. Kitsenko, D. N. Fedorov
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/196
id doaj-f54c49d7fcc945c68b4e58eb8bc79533
record_format Article
spelling doaj-f54c49d7fcc945c68b4e58eb8bc795332021-07-28T13:06:06ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-01276879510.22416/1382-4376-2017-27-6-87-95196Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)P. V. Tsarkov0I. A. Tulina1S. K. Efetov2Yu. E. Kitsenko3D. N. Fedorov4Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityFederal state government-financed institution «Petrovsky National Research Center of Surgery»Aim of investigation. To compare results of radical surgery in IBD-associated colorectal cancer (IBD-CRC) and sporadic colorectal cancer (spCRC) patients. Material and methods. The main group included retrospective cases of IBD-CRC with total colectomy and D3 lymph node (LN) dissection. The control group included matched cases of spCRC in 1:3 ratio according to localization and stage. Results. Overall 6 IBD-CRC and 18 spCRC patients were matched. IBD-CRC patients had longer operation time (313±37 vs 240±16 min, p=0.05), while there was no significant difference in mean volume of blood loss and postoperative stay duration (383±145 and 186±29 ml, p=0.24; 15.7±3.2 and 14.1±0.9 days, p=0.5 respectively). IBD-CRC patients spent longer time in ICU than spCRC (2.3±0.6 and 1.17±0.2 days, p=0.02) and had later bowel peristalsis restoration (2.0±0.4 and 1.3±0.1 days, p=0.02), however, time to first gas and stool discharge via stoma didn’t differ (2.5±1.4 and 2.1±0.6 days, p=0.5; 4.2±3.4 and 2.4±0.7 days, p=0.3). Tumor grade, histological type and adenoma rate didn’t differ between groups. Average number of involved LN in IBDCRC and spCRC was 39±16 and 30±5 (p=0.6). The rate of metastatic LN was 33.3% in both groups. The mean follow-up time was 27.3±5.3 months. Distant metastases were detected in 33.3% and 16.7% of IBD-CRC and spCRC cases respectively (p=0.4), without local recurrence in both groups. Conclusion. Tumor and LN characteristics in spCRC and IBD-CRC were similar, therefore radical surgery with extended LN dissection is recommended for IBDCRC patients.https://www.gastro-j.ru/jour/article/view/196неспецифические воспалительные заболевания кишечникаязвенный колитболезнь кронаколоректальный ракрасширенная лимфодиссекция
collection DOAJ
language Russian
format Article
sources DOAJ
author P. V. Tsarkov
I. A. Tulina
S. K. Efetov
Yu. E. Kitsenko
D. N. Fedorov
spellingShingle P. V. Tsarkov
I. A. Tulina
S. K. Efetov
Yu. E. Kitsenko
D. N. Fedorov
Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
неспецифические воспалительные заболевания кишечника
язвенный колит
болезнь крона
колоректальный рак
расширенная лимфодиссекция
author_facet P. V. Tsarkov
I. A. Tulina
S. K. Efetov
Yu. E. Kitsenko
D. N. Fedorov
author_sort P. V. Tsarkov
title Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)
title_short Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)
title_full Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)
title_fullStr Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)
title_full_unstemmed Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)
title_sort safety and efficacy of total colectomy with d3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)
publisher Gastro LLC
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
issn 1382-4376
2658-6673
publishDate 2018-08-01
description Aim of investigation. To compare results of radical surgery in IBD-associated colorectal cancer (IBD-CRC) and sporadic colorectal cancer (spCRC) patients. Material and methods. The main group included retrospective cases of IBD-CRC with total colectomy and D3 lymph node (LN) dissection. The control group included matched cases of spCRC in 1:3 ratio according to localization and stage. Results. Overall 6 IBD-CRC and 18 spCRC patients were matched. IBD-CRC patients had longer operation time (313±37 vs 240±16 min, p=0.05), while there was no significant difference in mean volume of blood loss and postoperative stay duration (383±145 and 186±29 ml, p=0.24; 15.7±3.2 and 14.1±0.9 days, p=0.5 respectively). IBD-CRC patients spent longer time in ICU than spCRC (2.3±0.6 and 1.17±0.2 days, p=0.02) and had later bowel peristalsis restoration (2.0±0.4 and 1.3±0.1 days, p=0.02), however, time to first gas and stool discharge via stoma didn’t differ (2.5±1.4 and 2.1±0.6 days, p=0.5; 4.2±3.4 and 2.4±0.7 days, p=0.3). Tumor grade, histological type and adenoma rate didn’t differ between groups. Average number of involved LN in IBDCRC and spCRC was 39±16 and 30±5 (p=0.6). The rate of metastatic LN was 33.3% in both groups. The mean follow-up time was 27.3±5.3 months. Distant metastases were detected in 33.3% and 16.7% of IBD-CRC and spCRC cases respectively (p=0.4), without local recurrence in both groups. Conclusion. Tumor and LN characteristics in spCRC and IBD-CRC were similar, therefore radical surgery with extended LN dissection is recommended for IBDCRC patients.
topic неспецифические воспалительные заболевания кишечника
язвенный колит
болезнь крона
колоректальный рак
расширенная лимфодиссекция
url https://www.gastro-j.ru/jour/article/view/196
work_keys_str_mv AT pvtsarkov safetyandefficacyoftotalcolectomywithd3lymphnodedissectionatcolorectalcancerdevelopedatinflammatoryboweldiseasescasecontrolstudy
AT iatulina safetyandefficacyoftotalcolectomywithd3lymphnodedissectionatcolorectalcancerdevelopedatinflammatoryboweldiseasescasecontrolstudy
AT skefetov safetyandefficacyoftotalcolectomywithd3lymphnodedissectionatcolorectalcancerdevelopedatinflammatoryboweldiseasescasecontrolstudy
AT yuekitsenko safetyandefficacyoftotalcolectomywithd3lymphnodedissectionatcolorectalcancerdevelopedatinflammatoryboweldiseasescasecontrolstudy
AT dnfedorov safetyandefficacyoftotalcolectomywithd3lymphnodedissectionatcolorectalcancerdevelopedatinflammatoryboweldiseasescasecontrolstudy
_version_ 1721277015542202368